Allergan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

25.04.17	Allergan Granted Marketing Authorization by the FDA for TrueTear™, the First Intranasal Neurostimulating Device Proven to Temporarily Increase Tear Production (PR Newswire)
20.04.17	Allergan Announces 13 Presentations on Chronic Migraine, Upper and Lower Limb Spasticity, Cervical Dystonia and Alzheimer's Disease at the American Academy of Neurology Meeting in Boston (PR Newswire)
20.04.17	Allergan Partners with TARGET PharmaSolutions to Advance NASH Research (PR Newswire)
18.04.17	Allergan, Novartis In Clinical Trial Deal To Treat NASH - Quick Facts (RTTNews)
18.04.17	Novartis Collaborates With Allergan On NASH - Quick Facts (RTTNews)
18.04.17	Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration (PR Newswire)
11.04.17	Allergan Launches Frames of Mind, Encouraging People Living with Migraine to Share Common Experiences Through Art (PR Newswire)
10.04.17	Allergan Receives 2017 ENERGY STAR® Partner of the Year - Sustained Excellence Award from U.S. Environmental Protection Agency (PR Newswire)
07.04.17	Allergan Teams Up With Media Mogul Wendy Williams to Debut the Patient Empowerment Campaign - Toilet Talk (PR Newswire)
07.04.17	Aegon Publishes Agenda for 2017 Annual General Meeting (PR Newswire)
07.04.17	Aegon Publishes Agenda for 2017 Annual General Meeting (PR Newswire)
06.04.17	Allergan Names Daphne Karydas as Senior Vice President of Global Investor Relations & Strategy (PR Newswire)
06.04.17	Rivel Releases Unprecedented International Study on Guidance Showing Deep Concern over Consensus Earnings and Short-term Volatility (PR Newswire)
06.04.17	Allergan and ZELTIQ Announce Expiration of Hart-Scott-Rodino Waiting Period for Pending Transaction (PR Newswire)
05.04.17	Allergan Reports Topline Phase II Data Supporting Advancement of BOTOX® (onabotulinumtoxinA) for the Treatment of Major Depressive Disorder (MDD) (PR Newswire)
05.04.17	Allergan to Report First Quarter 2017 Earnings and Host Conference Call and Webcast (PR Newswire)
04.04.17	Regenerative Technology Innovations in the Medical Market (PR Newswire)
28.03.17	FDA Nod For TSRO, Déjà Vu For ARQL, FOMX Plunges On Trial Data, SELB Abuzz (RTTNews)
27.03.17	Allergan, Paratek Report Positive Results From Two Phase 3 Trials Of Sarecycline (RTTNews)
27.03.17	Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline for the Treatment of Moderate to Severe Acne (PR Newswire)
24.03.17	Aegon Publishes 2016 Annual Report and Review (PR Newswire)
24.03.17	Aegon Publishes 2016 Annual Report and Review (PR Newswire)
23.03.17	Generic Drugs Stocks on Investors' Radar -- Mylan, Allergan, Horizon Pharma, and Evoke Pharma (PR Newswire)
22.03.17	Allergan Announces Availability of RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsion) 0.05% -- the First FDA-Approved Preservative Free Prescription Eye Drop Available in a Multidose Bottle (PR Newswire)
20.03.17	Allergan Says FDA Approves JUVÉDERM VOLLURE XC (RTTNews)
15.03.17	FDA Panel Snubs ENDP, Watch Out For TCON, MRK's Keytruda Scores Another Win (RTTNews)
14.03.17	New Survey Reveals Impact Of Double Chin On Self-Perception And Behavior (PR Newswire)
14.03.17	Award Winning Actor And Hip-Hop Artist Common Joins Allergan's See America(SM) Initiative To Further The Fight Against Preventable Blindness (PR Newswire)
14.03.17	Allergan To Receive Option To License Editas Medicine's Ocular Programs (RTTNews)
14.03.17	Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases (PR Newswire)
14.03.17	Pfizer Launches Zavicefta In The U.K. & Germany - Quick Facts (RTTNews)
13.03.17	OilPrice.com: The Next Big Biotech Breakthrough Could Just be on the Horizon (PR Newswire)
09.03.17	Allergan plc Question if a Feminist Can Love Fillers? (PR Newswire)
03.03.17	Allergan Presents Data From 21 Abstracts At The 2017 American Academy Of Dermatology Meeting In Orlando, FL (PR Newswire)
02.03.17	Allergan to Present at the Barclays Global Healthcare Conference (PR Newswire)
27.02.17	Allergan to Present at Raymond James 38th Annual Institutional Investors Conference (PR Newswire)
17.02.17	Aegon Responds to Inaccurate Information (PR Newswire)
17.02.17	Aegon Responds to Inaccurate Information (PR Newswire)
17.02.17	Aegon Reports Strong Net Income in Q4 2016 (PR Newswire)
17.02.17	Aegon Reports Strong Net Income in Q4 2016 (PR Newswire)
15.02.17	Medicines360 And Allergan Announce Partnership With Health Centers To Help Address Unintended Pregnancies In Areas Impacted By Zika (PR Newswire)
13.02.17	Allergan To Acquire ZELTIQ For $2.475 Bln - Quick Facts (RTTNews)
13.02.17	Allergan to Acquire ZELTIQ, Best-in-Class Company in Fast-Growing Body Contouring Segment, for $2.47 Billion (PR Newswire)
09.02.17	AASLD Foundation's Liver Disease Research and Education Initiatives Bolstered by Significant Donation from Allergan (PR Newswire)
08.02.17	EARNINGS SUMMARY: Details of Allergan Inc. Q4 Earnings Report (RTTNews)
08.02.17	Allergan Reports Strong 2016 Finish with 7% Increase in GAAP Net Revenues to $3.9 Billion in Fourth Quarter 2016 (PR Newswire)
07.02.17	How These Generic Drugs Stocks are Faring? -- Mylan, Allergan, Horizon Pharma, and Catalent (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

09.02.20		Ausblick: Allergan veröffentlicht Zahlen zum vergangenen Quartal
04.10.19		Molecular Partners-Aktie gefragt: Molecular Partners kündigt neue Daten vom Partner Allergan zu Augenmittel an
04.08.19		Ausblick: Allergan stellt Ergebnisse des abgelaufenen Quartals vor
05.05.19		Ausblick: Allergan informiert über die jüngsten Quartalsergebnisse
19.02.18		Molecular Partners: Partner Allergan zieht weitere Option für DARPin-Kandidaten
22.12.17		Novartis erreicht Zwischenerfolg in Patentstreit mit Allergan

09.02.20

Ausblick: Allergan veröffentlicht Zahlen zum vergangenen Quartal

04.10.19

Molecular Partners-Aktie gefragt: Molecular Partners kündigt neue Daten vom Partner Allergan zu Augenmittel an

04.08.19

Ausblick: Allergan stellt Ergebnisse des abgelaufenen Quartals vor

05.05.19

Ausblick: Allergan informiert über die jüngsten Quartalsergebnisse

19.02.18

Molecular Partners: Partner Allergan zieht weitere Option für DARPin-Kandidaten

22.12.17

Novartis erreicht Zwischenerfolg in Patentstreit mit Allergan

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Allergan plc

Aktien Top/Flop

Allergan Peer Group Nachrichten

Meistgelesene Nachrichten